Your browser doesn't support javascript.
loading
ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.
Hoogland, A Marije; Jenster, Guido; van Weerden, Wytske M; Trapman, Jan; van der Kwast, Theo; Roobol, Monique J; Schröder, Fritz H; Wildhagen, Mark F; van Leenders, Geert Jlh.
Affiliation
  • Hoogland AM; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. A.M.Hoogland@erasmusmc.nl
Mod Pathol ; 25(3): 471-9, 2012 Mar.
Article in En | MEDLINE | ID: mdl-22080055

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Adenocarcinoma / Biomarkers, Tumor / Trans-Activators / Prostate-Specific Antigen / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2012 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Adenocarcinoma / Biomarkers, Tumor / Trans-Activators / Prostate-Specific Antigen / Neoplasm Recurrence, Local Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2012 Type: Article Affiliation country: Netherlands